Life ScienceCompany
Aratana Therapeutics M&A Summary
Aratana Therapeutics has acquired 2 companies of its own.
Aratana Therapeutics’ largest acquisition to date was in 2013, when it acquired Vet Therapeutics for $30M. Aratana Therapeutics has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include healthcare services (50%) and life science (50%).
Aratana Therapeutics Ownership
Who owns Aratana Therapeutics?
Aratana Therapeutics is owned by Elanco Animal Health. It was acquired on April 26, 2019.
Aratana Therapeutics Business Overview
Where is Aratana Therapeutics headquartered?
Aratana Therapeutics is headquartered in Leawood, Kansas.
What is Aratana Therapeutics’ revenue?
Aratana Therapeutics disclosed revenue of 35M USD for 2018 and 26M USD for 2017.
How many employees does Aratana Therapeutics have?
Aratana Therapeutics has 83 employees.
What sector is Aratana Therapeutics in?
Aratana Therapeutics is a life science company.
When was Aratana Therapeutics founded?
Aratana Therapeutics was founded in 2010.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 2
- Total Countries Invested 2
Unlimited Searches
